Clinical efficacy of immune checkpoint inhibitors for cancer of unknown primary: a multi-center retrospective study

Abstract Background Patients diagnosed with cancer of unknown primary (CUP) have limited treatment options, resulting in a dismal prognosis. The efficacy of immune checkpoint inhibitors (ICIs) in these patients is still unclear. Methods We collected the clinical data of these patients retrospectivel...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Haowen Wang, Siqi Song, Yuzhou Nie, Jinting Wu, Linyue Pan, Qizhen Zou, Gaizhen Kuang, Chen Chen, Xiaochen Zhang, Wenfeng Li, Shirong Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-08-01
coleção:	BMC Cancer
Assuntos:	CUP ICIs Unfavorable subgroup Immunotherapy Survival.
Acesso em linha:	https://doi.org/10.1186/s12885-025-14778-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!